Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Pretargeted Radioimmunotherapy using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma
Clinical Cancer Research (2011)
  • Steven I Park, University of North Carolina at Chapel Hill
  • Jaideep Shenoi, University of Washington
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • Donald K Hamlin, University of Washington
  • Yukang Lin, Fred Hutchinson Cancer Research Center
  • D. Scott Wilbur, University of Washington
  • Patrick S Stayton, University of Washington
  • Nural N. Orgun, Fred Hutchinson Cancer Research Center
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • Franz Buchegger, University of Lausanne
  • Aimee L. Kenoyer, Fred Hutchinson Cancer Research Center
  • Amanda Axtman, Fred Hutchinson Cancer Research Center
  • Ajay K Gopal, University of Washington
  • Damian J. Green, University of Washington
  • John M Pagel, University of Washington
  • Oliver W. Press, University of Washington
Link
Disciplines
Publication Date
December 1, 2011
DOI
10.1158/1078-0432.CCR-11-1204
Citation Information
Steven I Park, Jaideep Shenoi, Shani L. Frayo, Donald K Hamlin, et al.. "Pretargeted Radioimmunotherapy using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma" Clinical Cancer Research Vol. 17 Iss. 23 (2011) p. 7373 - 7382
Available at: http://works.bepress.com/john-pagel/163/